" /> Pseudohypoaldosteronism, type I, autosomal dominant - CISMeF





Preferred Label : Pseudohypoaldosteronism, type I, autosomal dominant;

Symbol : PHA1A;

CISMeF acronym : PHA1A;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Pha I, autosomal dominant;

Description : Autosomal dominant pseudohypoaldosteronism type I is characterized by salt wasting resulting from renal unresponsiveness to mineralocorticoids. Patients may present with neonatal renal salt wasting with hyperkalaemic acidosis despite high aldosterone levels. These patients improve with age and usually become asymptomatic without treatment. Some adult patients with the disorder may have elevated aldosterone levels, but no history of clinical disease. This observation suggests that only those infants whose salt homeostasis is stressed by intercurrent illness and volume depletion develop clinically recognized PHA I (summary by Geller et al., 1998). Autosomal recessive PHA (PHA1B; 264350), caused by mutation in any one of 3 genes encoding the epithelial sodium channel (ENaC), is a similar but more severe systemic disorder with persistence into adulthood.;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the nuclear receptor subfamily 3, group C, member 2 gene (NR3C2, 600983.0001);

Laboratory abnormalities : Hyponatremia; Hyperkalemia; Increased serum aldosterone; Increased plasma renin activity;

Prefixed ID : #177735;

Details


You can consult :


Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.